Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

15.11
Delayed Data
As of Aug 27
 +0.75 / +5.22%
Today’s Change
11.93
Today|||52-Week Range
32.82
-17.21%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues1.1M1.5M486.0K2.2M
 
 
 
 
 
Depreciation And Amortization857.0K877.0K925.0K966.0K
 
 
 
 
 
 
Operating ExpensesGross Income244.0K600.0K----
 
 
 
General Expenses30.6M32.7M30.5M34.0M
 
 
 
 
 
Research And Development26.2M26.4M25.1M26.5M
 
 
 
 
 
Total Operating Expenses31.4M33.5M31.5M34.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-30.3M-32.1M-31.0M-32.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-28.1M-31.8M-30.2M-32.4M
 
 
 
 
 
Net Income-28.1M-31.8M-30.2M-32.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS89.4M89.6M92.4M98.5M
 
 
 
 
 
Shares To Calculate EPS Diluted89.4M89.6M92.4M98.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.31-$0.36-$0.33-$0.33
 
 
 
 
 
EPS Diluted-$0.31-$0.36-$0.33-$0.33